Mail

UK markets close in 3 hours 6 minutes

FTSE 100
8,299.61
+86.12(+1.05%)
FTSE 250
20,396.17
+231.63(+1.15%)
AIM
777.65
+6.12(+0.79%)
GBP/EUR
1.1649
-0.0010(-0.09%)
GBP/USD
1.2550
-0.0014(-0.11%)
Bitcoin GBP
50,694.30
-390.10(-0.76%)

The retirement income gap no-one is talking about

People are living longer than ever before and this can impact how you plan for retirement

Rakovina Therapeutics Inc. (RKV.V)

TSXV - TSXV Real-time price. Currency in CAD

Add to watchlist

0.0900

0.0000

(0.00%)

At close: 01:15PM EDT

Currency in CAD

Valuation measures⁴

Market cap (intra-day)	6.28M
Enterprise value	6.79M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	N/A
Price/book (mrq)	1.45
Enterprise value/revenue	N/A
Enterprise value/EBITDA	-3.49

Trading information

Stock price history

Beta (5Y monthly)	0.19
52-week change ³	-37.93%
S&P500 52-week change ³	25.77%
52-week high ³	0.1600
52-week low ³	0.0050
50-day moving average ³	0.0826
200-day moving average ³	0.0889

Share statistics

Avg vol (3-month) ³	74.22k
Avg vol (10-day) ³	32.8k
Shares outstanding ⁵	69.83M
Implied shares outstanding ⁶	69.83M
Float ⁸	37.74M
% held by insiders ¹	45.76%
% held by institutions ¹	0.00%
Shares short (30 Apr 2024) ⁴	5.68k
Short ratio (30 Apr 2024) ⁴	0.05
Short % of float (30 Apr 2024) ⁴	N/A
Short % of shares outstanding (30 Apr 2024) ⁴	0.01%
Shares short (prior month 28 Mar 2024) ⁴	1.24k

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2022
Most-recent quarter (mrq)	30 Sept 2023

Profitability

Profit margin	0.00%
Operating margin (ttm)	0.00%

Management effectiveness

Return on assets (ttm)	-24.37%
Return on equity (ttm)	-46.37%

Income statement

Revenue (ttm)	N/A
Revenue per share (ttm)	N/A
Quarterly revenue growth (yoy)	N/A
Gross profit (ttm)	N/A
EBITDA	-1.94M
Net income avi to common (ttm)	-2.54M
Diluted EPS (ttm)	-0.0400
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	813.33k
Total cash per share (mrq)	0.01
Total debt (mrq)	1.31M
Total debt/equity (mrq)	30.37%
Current ratio (mrq)	6.39
Book value per share (mrq)	0.06

Cash flow statement

Operating cash flow (ttm)	-1.93M
Levered free cash flow (ttm)	-1.02M